US2012283438A1PendingUtilityA1

Compounds

Assignee: LAZARIDES LINOSPriority: Feb 19, 2007Filed: Jul 18, 2012Published: Nov 8, 2012
Est. expiryFeb 19, 2027(~0.6 yrs left)· nominal 20-yr term from priority
A61P 37/00A61P 37/04A61P 35/04A61P 37/08A61P 29/00A61P 31/00A61P 35/00C07D 473/16A61P 11/02A61P 11/06C07D 473/18
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.

Claims

exact text as granted — not AI-modified
1 . A process for the preparation of a compound of formula (I): 
       
         
           
           
               
               
           
         
         wherein;
 R 1  is C 1-8 alkylamino, C 1-8 alkoxy, C 3-7 cycloalkylC 1-6 alkylamino, C 3-7 cycloalkylC 1-6 alkoxy, C 1-3 alkoxyC 2-3 alkoxy, or Het b -C 1-3 alkoxy; 
 Het b  is a 5- or 6-membered saturated aliphatic heterocyle containing one oxygen atom; 
 R 2  is —(CH 2 ) n -Het; 
 n is an integer having a value of 1 to 4; 
 Het is a 5- or 6-membered saturated aliphatic heterocycle containing one oxygen heteroatom, which heterocycle may be substituted by one or two C 1-4 alkyl groups; 
 
         or a salts or a solvates thereof, comprising the deprotection of a compound of formula (IIA): 
       
       
         
           
           
               
               
           
         
         wherein R 1  and R 2  are as hereinbefore defined for a compound of formula (I) and R 3  is C 1-6 alkyl. 
       
     
     
         2 . A process for the preparation of a compound of formula (I): 
       
         
           
           
               
               
           
         
         wherein;
 R 1  is C 1-8 alkylamino, C 1-8 alkoxy, C 3-7 cycloalkylC 1-6 alkylamino, C 3-7 cycloalkylC 1-6 alkoxy, C 1-3 alkoxyC 2-3 alkoxy, or Het b -C 1-3 alkoxy; 
 Het b  is a 5- or 6-membered saturated aliphatic heterocyle containing one oxygen atom; 
 R 2  is —(CH 2 ) n —Het; 
 n is an integer having a value of 1 to 4; 
 Het is a 5- or 6-membered saturated aliphatic heterocycle containing one oxygen heteroatom, which heterocycle may be substituted by one or two C 1-4 alkyl groups; 
 
         or a salt or a solvate thereof, comprising the hydrolysis of a compound of formula (XXI): 
       
       
         
           
           
               
               
           
         
         wherein R 1  and R 2  are as hereinbefore defined for a compound of formula (I) and X is a halogen atom. 
       
     
     
         3 . A process for the preparation of a compound of formula (I): 
       
         
           
           
               
               
           
         
         wherein;
 R 1  is C 1-8 alkylamino, C 1-8 alkoxy, C 3-7 cycloalkylC 1-6 alkylamino, C 3-7 cycloalkylC 1-6 alkoxy, C 1-3 alkoxyC 2-3 alkoxy, or Het b -C 1-3 alkoxy; 
 Het b  is a 5- or 6-membered saturated aliphatic heterocyle containing one oxygen atom; 
 R 2  is —(CH 2 ) n -Het; 
 n is an integer having a value of 1 to 4; 
 Het is a 5- or 6-membered saturated aliphatic heterocycle containing one oxygen heteroatom, which heterocycle may be substituted by one or two C 1-4 alkyl groups; 
 
         or a salt or a solvate thereof, comprising the reaction of a compound of formula (XXIII): 
       
       
         
           
           
               
               
           
         
         wherein Y is a halogen atom, R 2  is as hereinbefore defined for a compound of formula (I), and R 3  is C 1-6 alkyl, with a compound of formula (VIB)
   R 1 —H  (VIB)
 
 
         wherein R 1  is C 1-8 alkylamino or C 3-7 cycloalkylC 1-6 alkylamino. 
       
     
     
         4 . A process according to  claim 1  further comprising the steps of at least one of:
 (i). converting a compound of formula (I) to a further compound of formula (I), and; 
 (ii). preparing a salt or solvate of the resulting compound. 
 
     
     
         5 . A process according to  claim 2  further comprising the steps of at least one of:
 (i). converting a compound of formula (I) to a further compound of formula (I), and; 
 (ii). preparing a salt or solvate of the resulting compound. 
 
     
     
         6 . A process according to  claim 3  further comprising the steps of at least one of:
 (i). converting a compound of formula (I) to a further compound of formula (I), and; 
 (ii). preparing a salt or solvate of the resulting compound.

Join the waitlist — get patent alerts

Track US2012283438A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.